1887

Chapter 25 : Foot-and-Mouth Disease

Authors: Marvin J. Grubman1, Luis L. Rodriguez2, Teresa de los Santos3
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Plum Island Animal Disease Center, North Atlantic Area, Agricultural Research Service, U.S. Department of Agriculture, Greenport, NY 11944; 2: Plum Island Animal Disease Center, North Atlantic Area, Agricultural Research Service, U.S. Department of Agriculture, Greenport, NY 11944; 3: Plum Island Animal Disease Center, North Atlantic Area, Agricultural Research Service, U.S. Department of Agriculture, Greenport, NY 11944
Content Type: Monograph
Publication Year: 2010

Category: Viruses and Viral Pathogenesis

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Foot-and-Mouth Disease, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816698/9781555816032_Chap25-1.gif /docserver/preview/fulltext/10.1128/9781555816698/9781555816032_Chap25-2.gif

Abstract:

Foot-and-mouth disease (FMD) is a highly infectious viral disease of domestic cloven-hoofed animals, including cattle, swine, goats, and sheep, as well as some species of wild animals. The viral agent, FMD virus (FMDV), is the type species of the genus of the family. The major consequence of FMD is a high degree of morbidity, including fever, lameness, and vesicular lesions on the tongue, feet, snout, and teats, but there is generally low mortality in infected animals except when the disease affects the young. Additional research with naturally susceptible animals is necessary to understand the mechanism of immunosuppression FMDV has developed and to identify the viral protein(s) that participates in this process. In addition to the high genetic variation, other mechanisms involving interaction of specific viral proteins or interactions of 5’ and 3’ untranslated regions (UTRs) with cellular targets have been shown to contribute to its virulence. In vitro studies have shown that after FMDV infection of BHK cells several proteins, including poly(A)-binding protein, polypyrimidine tract-binding protein (PTBP), and two subunits of the translation factor eIF3 (eIF3a and -b) undergo proteolytic cleavage. It is hoped that new information obtained from comprehensive viral pathogenesis studies will enable researchers to develop more effective disease control strategies, including induction of rapid protective responses to inhibit or at least limit the spread of this disease.

Citation: Grubman M, Rodriguez L, Santos T. 2010. Foot-and-Mouth Disease, p 397-410. In Ehrenfeld E, Domingo E, Roos R (ed), The Picornaviruses. ASM Press, Washington, DC. doi: 10.1128/9781555816698.ch25
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Foot-and-Mouth Disease
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816698.ch25-1,webId=/content/author/10.1128/9781555816698.ch25-1,properties={foaf_givenname=Marvin J., foaf_name=Marvin J. Grubman, foaf_surname=Grubman, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816698.ch25-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816698.ch25-2,webId=/content/author/10.1128/9781555816698.ch25-2,properties={foaf_givenname=Luis L., foaf_name=Luis L. Rodriguez, foaf_surname=Rodriguez, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816698.ch25-aff2]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816698.ch25-3,webId=/content/author/10.1128/9781555816698.ch25-3,properties={foaf_givenname=Teresa de los, foaf_name=Teresa de los Santos, foaf_surname=Santos, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816698.ch25-aff3]]}]]
Citation: Grubman M, Rodriguez L, Santos T. 2010. Foot-and-Mouth Disease, p 397-410. In Ehrenfeld E, Domingo E, Roos R (ed), The Picornaviruses. ASM Press, Washington, DC. doi: 10.1128/9781555816698.ch25
/content/10.1128/9781555816698.ch25.ch25fig01
Figure 1.
Schematic representation of the FMDV genome. The coding region of the genome is represented by shaded rectangles. Proteins that have been shown to be involved in the inhibition of host response, required for host receptor binding, and necessary for maximum virulence are indicated; their roles are further discussed in various sections of the text. PKs, pseudoknots.
10.1128/9781555816698/f0398-01_thmb.gif
10.1128/9781555816698/f0398-01.gif
Image of Figure 1.
Figure 1.

Schematic representation of the FMDV genome. The coding region of the genome is represented by shaded rectangles. Proteins that have been shown to be involved in the inhibition of host response, required for host receptor binding, and necessary for maximum virulence are indicated; their roles are further discussed in various sections of the text. PKs, pseudoknots.

Citation: Grubman M, Rodriguez L, Santos T. 2010. Foot-and-Mouth Disease, p 397-410. In Ehrenfeld E, Domingo E, Roos R (ed), The Picornaviruses. ASM Press, Washington, DC. doi: 10.1128/9781555816698.ch25
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816698.ch25
1. Alexandersen, S.,, Z. Zhang, and, A. I. Donaldson. 2002. Aspects of persistence of foot-and-mouth disease virus in animals: the carrier problem. Microbes Infect. 4:1099–1110.
2. Alexandersen, S.,, Z. Zhang,, A. I. Donaldson, and, A. J. M. Garland. 2003. The pathogenesis and diagnosis of foot-and-mouth disease. J. Comp. Pathol. 129:1–36.
3. Anderson, E. C. 1986. Potential for the transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle. Res. Vet. Sci. 40:278–280.
4. Andreev, D. E.,, O. Fernandez-Miragall,, J. Ramajo,, S. E. Dmitriev,, I. M. Terenin,, E. Martinez-Salas, and, I. N. Shatsky. 2007. Differential factor requirement to assemble translation initiation complexes at the alternative start codons of foot-and-mouth disease virus. RNA 13:1–9.
5. Arzt, J.,, J. M. Pacheco, and, L. L. Rodriguez. The early pathogenesis of foot-and-mouth disease in cattle after aerosol inoculation: identification of the nasopharynx as the primary site of infection. Vet. Pathol., in press.
6. Bablanian, G. M., and, M. J. Grubman. 1993. Characterization of the foot-and-mouth disease virus 3C protease expressed in Escherichia coli. Virology 197:320–327.
7. Bachrach, H. L. 1968. Foot-and-mouth disease. Annu. Rev. Microbiol. 22:201–244.
8. Balabanian, K.,, A. Foussat,, L. Bouchet-Delbos,, J. Couderc,, R. Krzysiek,, A. Amara,, F. Baleux,, A. Portier,, P. Galanaud, and, D. Emilie. 2002. Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant. Blood 99:427–436.
9. Baranowski, E.,, C. M. Ruiz-Jarabo,, N. Sevilla,, D. Andreu,, E. Beck, and, E. Domingo. 2000. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J. Virol. 74:1641–1647.
10. Baranowski, E.,, N. Sevilla,, N. Verdaguer,, C. M. Ruiz-Jarabo,, E. Beck, and, E. Domingo. 1998. Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J. Virol. 72:6362–6372.
11. Barnett, P. V., and, H. Carabin. 2002. A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine 20:1505–1514.
12. Barnett, P. V., and, S. J. Cox. 1999. The role of small ruminants in the epidemiology and transmission of foot-and-mouth disease. Vet. J. 158:6–13.
13. Bautista, E. M.,, G. S. Ferman, and, W. T. Golde. 2003. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot-and-mouth disease virus (FMDV). Vet. Immunol. Immunopathol. 92:61–73.
14. Bautista, E. M.,, G. S. Ferman,, D. Gregg,, M. C. S. Brum,, M. J. Grubman, and, W. T. Golde. 2005. Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J. Virol. 79:4838–4847.
15. Baxt, B., and, Y. Becker. 1990. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 4:73–83.
16. Baxt, B., and, P. W. Mason. 1995. Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor-mediated endocytosis. Virology 207:503–509.
17. Baxt, B., and, E. Rieder. 2004. Molecular aspects of foot-and-mouth disease virus virulence and host range: role of host cell receptors and viral factors, p. 145–172. In F. Sobrino and, E. Domingo (ed.), Foot and Mouth Disease: Current Perspectives. Horizon Bioscience, Norfolk, England.
18. Beard, C. W., and, P. W. Mason. 2000. Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J. Virol. 74:987–991.
19. Belsham, G. J., and, J. K. Brangwyn. 1990. A region of the 5′ noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: involvement with the role of L protease in translational control. J. Virol. 64:5389–5395.
20. Belsham, G. J.,, G. M. McInerney, and, N. Ross-Smith. 2000. Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within U8 infected cells. J. Virol. 74:272–280.
21. Bergmann, I. E.,, V. Malirat,, P. Auge de Mello, and, I. Gomes. 1996. Detection of foot-and-mouth disease viral sequences in various fluids and tissues during persistence of the virus in cattle. Am. J. Vet. Res. 57:134–137.
22. Berinstein, A.,, M. Roivainen,, T. Hovi,, P. W. Mason, and, B. Baxt. 1995. Antibodies to the vitronectin receptor (integrin αVβ3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 69:2664–2666.
23. Berryman, S.,, S. Clark,, P. Monaghan, and, T. Jackson. 2005. Early events in integrin αVβ6-mediated cell entry of foot-and-mouth disease virus. J. Virol. 79:8519–8534.
24. Borca, M. V.,, F. M. Fernandez,, A. M. Sadir,, M. Braun, and, A. A. Schudel. 1986. Immune response to foot-and-mouth disease virus in a murine experimental model: effective thymus-independent primary and secondary reaction. Immunology 59:261–267.
25. Brooksby, J. B. 1982. Portraits of viruses: foot-and-mouth disease virus. Intervirology 18:1–23.
26. Brown, C. C.,, M. E. Piccone,, P. W. Mason,, T. S. McKenna, and, M. J. Grubman. 1996. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J. Virol. 70:5638–5641.
27. Brown, J. K.,, S. M. McAleese,, E. M. Thornton,, J. A. Pate,, A. Schock,, A. I. Macrae,, P. R. Scott,, H. R. Miller, and, D. D. Collie. 2006. Integrin-αvβ6, a putative receptor for foot-and-mouth disease virus, is constitutively expressed in ruminant airways. J. Histochem. Cytochem. 54:807–816.
28. Burrows, R. 1968. Excretion of foot-and-mouth disease prior to the development of lesions. Vet. Rec. 82:387–388.
29. Burrows, R.,, J. A. Mann,, A. J. Garland,, A. Greig, and, D. Goodridge. 1981. The pathogenesis of natural and simulated natural foot-and-mouth disease infection in cattle. J. Comp. Pathol. 91:599–609.
30. Cao, X.,, I. E. Bergmann,, R. Fullkrug, and, E. Beck. 1995. Functional analysis of the two alternative translation initiation sites of foot-and-mouth disease virus. J. Virol. 69:560–563.
31. Capozzo A. V.,, D. J. Burke,, J. W. Fox,, I. E. Bergmann,, J. L. La Torre, and, P. R. Grigera. 2002. Expression of foot and mouth disease virus non-structural polypeptide 3ABC induces histone H3 cleavage in BHK21 cells. Virus Res. 90:91–99.
32. Carrillo, C.,, E. R. Tulman,, G. Delhon,, Z. Lu,, A. Carreno,, A. Vagnozzi,, G. F. Kutish, and, D. L. Rock. 2005. Comparative genomics of foot-and-mouth disease virus. J. Virol. 9:6487–6504.
33. Childerstone, A. J.,, L. Cedillo-Baron,, M. Foster-Cuevas, and, R. M. Parkhouse. 1999. Demonstration of bovine CD8+ T-cell responses to foot-and-mouth disease virus. J. Gen. Virol. 80:663–669.
34. Chinsangaram, J.,, M. Koster, and, M. J. Grubman. 2001. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 12:5498–5503.
35. Chinsangaram, J.,, P. W. Mason, and, M. J. Grubman. 1998. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 16:1516–1522.
36. Chinsangaram, J.,, M. E. Piccone, and, M. J. Grubman. 1999. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 73:9891–9898.
37. Clarke, B. E., and, D. V. Sangar. 1988. Processing and assembly of foot-and-mouth disease virus proteins using subgenomic RNA. J. Gen. Virol. 69:2313–2325.
38. Clarke, B. E.,, D. V. Sangar,, J. N. Burroughs,, S. E. Newton,, A. R. Carroll, and, D. J. Rowlands. 1985. Two initiation sites for foot-and-mouth disease virus polyprotein in vivo. J. Gen. Virol. 66:2615–2626.
39. Condy, J. B., and, R. S. Hedger. 1974. The survival of foot-and-mouth disease virus in African buffalo with non-transference of infection to domestic cattle. Res. Vet. Sci. 16:182–185.
40. Condy, J. B.,, R. S. Hedger,, C. Hamblin, and, I. T. Barnett. 1985. The duration of the foot-and-mouth disease virus carrier state in African buffalo (i) in the individual animal and (ii) in a free-living herd. Comp. Immunol. Microbiol. Infect. Dis. 8:259–265.
41. Costa Giomi, M. P.,, I. E. Bergmann,, E. A. Scodeller,, P. Auge de Mello,, L. Gomez, and, J. L. La Torre. 1984. Heterogeneity of the polyribocytidylic acid tract in aphthovirus: biochemical and biological studies of viruses carrying polyribocytidylic acid tracts of different lengths. J. Virol. 51:799–805.
42. Cottral, G. E.,, B. F. Cox, and, D. E. Baldwin. 1960. The survival of FMDV in cured and uncured meat. Am. J. Vet. Res. 21:288–297.
43. Dawe, P. S.,, K. Sorensen,, N. P. Ferris,, I. T. Barnett,, R. M. Armstrong, and, N. J. Knowles. 1994. Experimental transmission of foot-and-mouth disease virus from carrier African buffalo (Syncerus caffer) to cattle in Zimbabwe. Vet. Rec. 134:211–215.
44. de los Santos, T.,, S. de Avila Botton,, R. Weiblen, and, M. J. Grubman. 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80:1906–1914.
45. de los Santos, T.,, F. Diaz-San Segundo, and, M. J. Grubman. 2007. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 81:12803–12815.
46. de los Santos, T.,, F. Diaz-San Segundo,, J. Zhu,, M. Koster,, C. C. Dias, and, M. J. Grubman. 2009. A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function. J. Virol. 83:1800–1810.
47. Devaney, M. A.,, V. N. Vakharia,, R. E. Lloyd,, E. Ehrenfeld, and, M. J. Grubman. 1988. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J. Virol. 62:4407–4409.
48. Dhennin, L.,, G. Gayot, and, L. Dhennin. 1967. Test of the pharyngeal curette in the study of carriers of aphthae virus. Bull. Acad. Vet. Fr. 40:59–65. (In Italian.)
49. Diaz-San Segundo, F.,, T. Rodriguez-Calvo,, A. de Avila, and, N. Sevilla. 2009. Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10. PLoS One 4:e5659.
50. Diaz-San Segundo, F.,, F. J. Salguero,, A. de Avila,, M. M. de Marco,, M. A. Sanchez-Martin, and, N. Sevilla. 2006. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J. Virol. 80:2369–2379.
51. Doel, T. R. 2005. Natural and vaccine induced immunity to FMD. Curr. Top. Microbiol. Immunol. 288:103–131.
52. Domingo, E.,, C. Escarmis,, E. Baronowski,, C. M. Ruiz-Jarabo,, E. Carrillo,, J. I. Nuñez, and, F. Sobrino. 2003. Evolution of foot-and-mouth disease virus. Virus Res. 91:47–63.
53. Donnelly, M. L.,, G. Luke,, A. Mehrotra,, X. Li,, L. E. Hughes,, D. Gani, and, M. D. Ryan. 2001. Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip.’ J. Gen. Virol. 82:1013–1025.
54. Duque, H., and, B. Baxt. 2003. Foot-and-mouth disease virus receptors: comparison of bovine αv integrin utilization by type A and O viruses. J. Virol. 77:2500–2511.
55. Falk, M. M.,, P. R. Grigera,, I. E. Bergmann,, A. Zibert,, G. Multhaup, and, E. Beck. 1990. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J. Virol. 64:748–756.
56. Falk, M. M.,, F. Sobrino, and, E. Beck. 1992. VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J. Virol. 66:2251–2260.
57. Forss, S., and, H. Schaller. 1982. A tandem repeat gene in a picornavirus. Nucleic Acids Res. 10:6441–6450.
58. García-Briones, M.,, M. F. Rosas,, M. Ganzález-Magaldi,, M. A. Martín-Acebes,, F. Sobrino, and, R. Arma-Portela. 2006. Differential distribution of non-structural proteins of foot-and-mouth disease virus in BHK-21 cells. Virology 349:409–421.
59. Geering, W. A. 1967. Foot and mouth disease in sheep. Aust. Vet. J. 43:485–489.
60. Giraudo, A. T.,, E. Beck,, K. Strebel,, P. A. de Mello,, J. L. La Torre,, E. A. Scodeller, and, I. E. Bergmann. 1990. Identification of a nucleotide deletion in parts of polypeptide 3A in two independent attenuated aphthovirus strains. Virology 177:780–783.
61. Giraudo, A. T.,, A. Sagedahl,, I. E. Bergmann,, J. L. La Torre, and, E. A. Scodeller. 1987. Isolation and characterization of recombinants between attenuated and virulent aphthovirus strains. J. Virol. 61:419–425.
62. Golde, W. T.,, C. K. Nfon, and, F. N. Toka. 2008. Immune evasion during foot-and-mouth disease virus infection of swine. Immunol. Rev. 225:85–95.
63. Gorbalenya, A. E.,, E. V. Koonin, and, M. M. Lai. 1991. Putative papain related thiol proteases of positive-strand RNA viruses. Identification of rubi- and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, alpha- and coronaviruses. FEBS Lett. 288:201–205.
64. Grigera, P. R., and, S. G. Tisminetzky. 1984. Histone H3 modification in BHK cells infected with foot-and-mouth disease virus. Virology 136:10–19.
65. Grubman, M. J. 1980. The 5′ end of foot-and-mouth disease virion RNA contains a protein covalently linked to the nucleotide pUp. Arch. Virol. 63:311–315.
66. Grubman, M. J., and, B. Baxt. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465–493.
67. Grubman, M. J.,, M. P. Moraes,, F. Diaz-San Segundo,, L. Pena, and, T. de los Santos. 2008. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol. Med. Microbiol. 53:8–17.
68. Guarne, A.,, J. Tormo,, R. Kirchweger,, D. Pfistermueller,, I. Fita, and, T. Skern. 1998. Structure of the foot-and-mouth disease virus leader protease: a papain-like fold adapted for self-processing and eIF4G recognition. EMBO J. 17:7469–7479.
69. Gulbahar, M. Y.,, W. C. Davis,, T. Guvenc,, M. Yarim,, U. Parlak, and, Y. B. Kabak. 2007. Myocarditis associated with foot-and-mouth disease virus type O in lambs. Vet. Pathol. 44:589–599.
70. Gutierrez, A.,, E. Martinez-Salas,, B. Pintado, and, F. Sobrino. 1994. Specific inhibition of aphthovirus infection by RNAs transcribed from both the 5′ and the 3′ noncoding regions. J. Virol. 68:7426–7432.
71. Guzylack-Piriou, L.,, F. Bergamin,, M. Gerber,, K. C. MuCullough, and, A. Summerfield. 2006. Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. Eur. J. Immunol. 36:1674–1683.
72. Harris, T. J., and, F. Brown. 1977. Biochemical analysis of a virulent and an avirulent strain of foot-and-mouth disease virus. J. Gen. Virol. 34:87–105.
73. Hinton, T. M.,, F. Li, and, B. S. Crabb. 2000. Internal entry site-mediated translation initiation in equine rhinitis A virus: similarities to and differences from that of foot-and-mouth disease virus. J. Virol. 74:11708–11716.
74. Hollister, J. R.,, A. Vagnozzi,, N. J. Knowles, and, E. Rieder. 2008. Molecular and phylogenetic analysis of bovine rhinovirus type 2 shows it is closely related to foot-and-mouth disease virus. Virology 373:411–425.
75. Honda, K.,, H. Yanai,, A. Takaoka, and, T. Taniguchi. 2006. Regulation of the type I IFN induction: a current view. Int. Immunol. 17:1367–1378.
76. Jackson, T.,, F. M. Ellard,, R. A. Ghazaleh,, S. M. Brookes,, W. E. Blakemore,, A. H. Corteyn,, D. I. Stuart,, J. W. Newman, and, A. M. King. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70:5282–5287.
77. Jackson, T.,, A. P. Mould,, D. Sheppard, and, A. M. King. 2002. Integrin αVβ1 is a receptor for foot-and-mouth disease virus. J. Virol. 76:935–941.
78. Jackson, T.,, S. Clark,, S. Berryman,, A. Burman,, S. Cambier,, D. Mu,, S. Nishimura, and, A. M. King. 2004. Integrin αVβ8 functions as a receptor for foot-and-mouth disease virus: role of the β-chain cytodomain in integrin-mediated infection. J. Virol. 78:4533–4540.
79. Joshi, G.,, R. Sharma, and, N. K. Kakker. 2009. Phenotypic and functional characterization of T cells and in vitro replication of FMDV serotypes in bovine lymphocytes. Vaccine 27:6656–6661.
80. Juleff, N.,, M. Windsor,, E. Reid,, J. Seago,, Z. Zhang,, P. Monaghan,, I. W. Morrison, and, B. Charleston. 2008. Foot-and-mouth disease virus persists in the light zone of germinal centres. PLoS One 3:e3434.
81. Kirchweger, R.,, E. Ziegler,, B. J. Lamphear,, D. Waters,, H. D. Liebig,, W. Sommergruber,, F. Sobrino,, C. Hohenadl,, D. Blaas,, R. E. Rhoads, and, T. Skern. 1994. Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J. Virol. 68:5677–5684.
82. Kleina, L. G., and, M. J. Grubman. 1992. Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus. J. Virol. 66:7168–7175.
83. Kong, W.-P.,, G. D. Ghadge, and, R. P. Roos. 1994. Involvement of cardiovirus leader in host cell-restricted virus expression. Proc. Natl. Acad. Sci. USA 91:1796–1800.
84. Ku, B. K.,, S. B. Kim,, O. K. Moon,, S. J. Lee,, J. H. Lee,, Y. S. Lyoo,, H. J. Kim, and, J. H. Sur. 2005. Role of apoptosis in the pathogenesis of Asian and South American foot-and-mouth disease viruses in swine. J. Vet. Med. Sci. 67:1081–1088.
85. Kuhn, R.,, N. Luz, and, E. Beck. 1990. Functional analysis of the internal translation initiation site of foot-and-mouth disease virus. J. Virol. 64:4625–4631.
86. Lawrence, P., and, E. Rieder. 2009. Identification of RNA heli-case A (RHA) as a new host factor in the replication cycle of foot-and-mouth disease virus. J. Virol. 83:11356–11366.
87. Leippert, M.,, E. Beck,, F. Weiland, and, E. Pfaff. 1997. Point mutations within the βG-βH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells. J. Virol. 71:1046–1051.
88. Luz, N., and, E. Beck. 1990. A cellular 57 kDa protein binds to two regions of the internal translation site of foot-and-mouth disease virus. FEBS Lett. 269:311–314.
89. Luz, N., and, E. Beck. 1991. Interaction of a cellular 57-kilo-dalton protein with the internal translation initiation site of foot-and-mouth disease virus. J. Virol. 65:6486–6494.
90. Martin-Acebes, M. A.,, M. Gonzalez-Magaldi,, K. Sandvig,, F. Sobrino, and, R. Armas-Portela. 2007. Productive entry of type C foot-and-mouth disease virus into susceptible cultured cells requires clathrin and is dependent on the presence of plasma membrane cholesterol. Virology 369:105–118.
91. Martinez, M. A.,, N. Verdaguer,, M. G. Mateu, and, E. Domingo. 1997. Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. Proc. Natl. Acad. Sci. USA 94:6798–6802.
92. Martinez-Salas, E.,, R. Ramos,, E. Lafuente, and, S. Lopez de Quinto. 2001. Functional interactions in internal translation initiation directed by viral and cellular IRES elements. J. Gen. Virol. 82:973–984.
93. Martinez-Salas, E.,, J. C. Saiz,, M. Davila,, G. J. Belsham, and, E. Domingo. 1993. A single nucleotide substitution in the internal ribosome entry site of foot-and-mouth disease virus leads to enhanced cap-independent translation in vivo. J. Virol. 67:3748–3755.
94. Mason, P. W.,, B. Baxt,, F. Brown,, J. Harber,, A. Murdin, and, E. Wimmer. 1993. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology 192:568–577.
95. Mason, P. W.,, S. V. Bezborodova, and, T. M. Henry. 2002. Identification and characterization of a cis -acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J. Virol. 76:9686–9694.
96. Mason, P. W.,, M. E. Piccone,, T. S. McKenna,, J. Chinsangaram, and, M. J. Grubman. 1997. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227:96–102.
97. Mason, P. W.,, E. Rieder, and, B. Baxt. 1994. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can by bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA 91:1932–1936.
98. McCullough, K. C.,, F. de Simone,, E. Brocchi,, L. Capucci,, J. R. Crowther, and, U. Kihm. 1992. Protective immune response against foot-and-mouth disease. J. Virol. 66:1835–1840.
99. McCullough, K. C.,, D. Parkinson, and, J. R. Crowther. 1988. Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology 65:187–191.
100. McKenna, T. S.,, J. Lubroth,, E. Rieder,, B. Baxt, and, P. W. Mason. 1995. Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J. Virol. 69:5787–5790.
101. McVicar, J. W., and, P. Sutmoller. 1969. The epizootiological importance of foot-and-mouth disease carriers. II. The carrier status of cattle exposed to foot-and-mouth disease following vaccination with an oil adjuvant inactivated virus vaccine. Arch. Gesamte Virusforsch. 26:217–224.
102. Medina, M.,, E. Domingo,, J. K. Brangwyn, and, G. J. Belsham. 1993. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 194:355–359.
103. Mezencio, J. M.,, G. D. Babcock,, E. Kramer, and, F. Brown. 1999. Evidence for the persistence of foot-and-mouth disease virus in pigs. Vet. J. 157:213–217.
104. Moffat, K.,, G. Howell,, C. Knox,, G. J. Belsham,, P. Monaghan,, M. D. Ryan, and, T. Wileman. 2005. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. J. Virol. 79:4382–4395.
105. Moffat, K.,, C. Knox,, G. Howell,, S. J. Clark,, H. Yang,, G. J. Belsham,, M. Ryan, and, T. Wileman. 2007. Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2BC with 2C, and the site of inhibition is determined by the subcellular location of 2C. J. Virol. 81:1129–1139.
106. Monaghan, P.,, S. Gold,, J. Simpson,, Z. Zhang,, P. H. Weinreb,, S. M. Violette,, S. Alexandersen, and, T. Jackson. 2005. The αvβ6 integrin receptor for foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J. Gen. Virol. 86:2769–2780.
107. Moonen, P., and, R. Schrijver. 2000. Carriers of foot-and-mouth disease virus: a review. Vet. Q. 22:193–197.
108. Neff, S.,, D. Sa-Carvalho,, E. Rieder,, P. W. Mason,, S. D. Blystone,, E. J. Brown, and, B. Baxt. 1998. Foot-and-mouth disease virus virulent for cattle utilizes the integrin αvβ3 as its receptor. J. Virol. 72:3587–3594.
109. Newton, S. E.,, A. R. Carroll,, R. O. Campbell,, B. E. Clarke, and, D. J. Rowlands. 1985. The sequence of foot-and-mouth disease virus RNA to the 5′ side of the poly(C) tract. Gene 40:331–336.
110. Nfon, C. K.,, G. S. Ferman,, F. N. Toka,, D. A. Gregg, and, W. T. Golde. 2008. Interferon-α production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus. Viral Immunol. 21:68–77.
111. Nunez, J. I.,, E. Baranowski,, N. Molina,, C. M. Ruiz-Jarabo,, C. Sanchez,, E. Domingo, and, F. Sobrino. 2001. A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J. Virol. 75:3977–3983.
112. O’Donnell, V.,, M. LaRocco, and, B. Baxt. 2008. Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis. J. Virol. 82:9075–9085.
113. O’Donnell, V.,, M. LaRocco,, H. Duque, and, B. Baxt. 2005. Analysis of foot-and-mouth disease virus internalization events in cultured cells. J. Virol. 79:8506–8518.
114. O’Donnell, V.,, J. M. Pacheco,, D. Gregg, and, B. Baxt. 2009. Analysis of foot-and-mouth disease virus integrin receptor expression in tissues from naïve and infected cattle. J. Comp. Pathol. 141:98–112.
115. O’Donnell, V. K.,, J. M. Pacheco,, T. M. Henry, and, P. W. Mason. 2001. Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A. Virology 287:151–162.
116. Oldstone, M. B. A. 1991. Molecular anatomy of viral persistence. J. Virol. 65:6381–6386.
117. Ostrowski, M.,, M. Vermeulen,, O. Zabal,, J. R. Geffner,, A. M. Sadir, and, O. J. Lopez. 2005. Impairment of thymus-dependent responses by murine dendritic cells infected with foot-and-mouth disease virus. J. Immunol. 175:3971–3979.
118. Ostrowski, M.,, M. Vermeulen,, O. Zabal,, P. I. Zamorano,, A. M. Sadir,, J. R. Geffner, and, O. J. Lopez. 2007. The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes. J. Virol. 81:9357–9367.
119. Pacheco, J. M.,, J. Arzt, and, L. L. Rodriguez. 2010. Early events in the pathogenesis of foot-and-mouth disease in cattle after controlled aerosol exposure. Vet. J. 183:46–53.
120. Pacheco, J. M.,, T. M. Henry,, V. K. O’Donnell,, J. B. Gregory, and, P. W. Mason. 2003. Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus. J. Virol. 77:13017–13027.
121. Parks, G. D.,, G. M. Duke, and, A. C. Palmenberg. 1986. Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5′ noncoding sequences to the P3 region. J. Virol. 60:376–384.
122. Peng, J. M.,, S. M. Liang, and, C. M. Liang. 2004. VP1 of foot-and-mouth disease virus induces apoptosis via the Akt signaling pathway. J. Biol. Chem. 279:52168–52174.
123. Piccone, M. E.,, J. M. Pacheco,, S. J. Pauszek,, E. Kramer,, E. Rieder,, M. V. Borca, and, L. L. Rodriguez. 2009. The region between the two polyprotein initiation codons of foot-and-mouth disease virus is critical for virulence in cattle. Virology 396:152–159.
124. Piccone, M. E.,, S. Pauszek,, J. Pacheco,, E. Rieder,, E. Kramer, and, L. L. Rodriguez. 2009. Molecular characterization of a foot-and-mouth disease virus containing a 57-nucleotide insertion in the 3′ untranslated region. Arch. Virol. 154:671–676.
125. Piccone, M. E.,, E. Rieder,, P. W. Mason, and, M. J. Grubman. 1995. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J. Virol. 69:5376–5382.
126. Pilipenko, E. V.,, V. M. Blinov,, B. K. Chernov,, T. M. Dmitrieva, and, V. I. Agol. 1989. Conservation of the secondary structure elements of the 5′-untranslated region of cardio- and aphthovirus RNAs. Nucleic Acids Res. 17:5701–5711.
127. Pilipenko, E. V.,, S. V. Maslova,, A. N. Sinyakov, and, V. I. Agol. 1992. Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures. Nucleic Acids Res. 20:1739–1745.
128. Pilipenko, E. V.,, T. V. Pestova,, V. G. Kolupaeva,, E. V. Khitrina,, A. N. Poperechnaya,, V. I. Agol, and, C. U. Hellen. 2000. A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev. 14:2028–2045.
129. Pilipenko, E. V.,, K. V. Poperechny,, S. V. Maslova,, W. J. Melchers,, H. J. Slot, and, V. I. Agol. 1996. cis-element, oriR, involved in the initiation of (-) strand poliovirus RNA: a quasi-globular multi-domain RNA structure maintained by tertiary (‘kissing’) interactions. EMBO J. 15:5428–5436.
130. Rieder, E.,, A. Berinstein,, B. Baxt,, A. Kang, and, P. W. Mason. 1996. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus. Proc. Natl. Acad. Sci. USA 93:10428–10433.
131. Rieder, E.,, T. Bunch,, F. Brown, and, P. W. Mason. 1993. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67:5139–5145.
132. Rieder, E.,, T. Henry,, H. Duque, and, B. Baxt. 2005. Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. J. Virol. 79:12989–12998.
133. Rigden, R. C.,, C. P. Carrasco,, A. Summerfield, and, K. C. McCullough. 2002. Macrophage phagocytosis of foot-and-mouth disease virus may create infectious carriers. Immunology 106:537–548.
134. Robertson, B. H.,, M. J. Grubman,, G. N. Weddell,, D. M. Moore,, J. D. Welsh,, T. Fischer,, D. J. Dowbenko,, D. G. Yansura,, B. Small, and, D. G. Kleid. 1985. Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J. Virol. 54:651–660.
135. Rodríguez Pulido, M.,, P. Serrano,, M. Sáiz, and, E. Martínez-Salas. 2007. Foot-and-mouth disease virus infection induces proteolytic cleavage of PTB, eIF3a, b, and PABP RNA-binding proteins. Virology 364:466–474.
136. Rodríguez Pulido, M.,, F. Sobrino,, B. Borrego, and, M. Sáiz. 2009. Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3′ noncoding region can elicit immunity in swine. J. Virol. 83:3475–3485.
137. Rohll, J. B.,, D. H. Moon,, D. J. Evans, and, J. W. Almond. 1995. The 3′ untranslated region of picornavirus RNA: features required for efficient genome replication. J. Virol. 69:7835–7844.
138. Rust, R. C.,, K. Ochs,, K. Meyer,, E. Beck, and, M. Niepmann. 1999. Interaction of eukaryotic initiation factor eIF4B with the internal ribosome entry site of foot-and-mouth disease virus is independent of the polypyrimidine tract-binding pro-tern. J. Virol. 73:6111–6113.
139. Ryan, E.,, D. Mackay, and, A. Donaldson. 2008. Foot-and-mouth disease virus concentrations in products of animal origin. Transbound. Emerg. Dis. 55:89–98.
140. Ryan, M. D.,, A. M. King, and, G. P. Thomas. 1991. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 72:2727–2732.
141. Sa-Carvalho, D.,, E. Rieder,, B. Baxt,, R. Rodarte,, A. Tanuri, and, P. W. Mason. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 71:5115–5123.
142. Sagedahl, A.,, A. T. Giraudo,, P. A. De Mello,, I. E. Bergmann,, J. L. La Torre, and, E. A. Scodeller. 1987. Biochemical characterization of an aphthovirus type C3 strain Resende attenuated for cattle by serial passages in chicken embryos. Virology 157:366–374.
143. Saiz, M.,, S. Gomez,, E. Martínez-Salas, and, F. Sobrino. 2001. Deletion or substitution of the aphthovirus 3′ NCR abrogates infectivity and virus replication. J. Gen. Virol. 82:93–101.
144. Salt, J. S. 1993. The carrier state in foot and mouth disease: an immunological review. Br. Vet. J. 149:207–223.
145. Salt, J. S. 1998. Persistent infection with foot-and-mouth disease virus. Top. Trop. Virol. 1:77–128.
146. Sanz-Parra, A.,, F. Sobrino, and, V. Ley. 1998. Infection with foot-and-mouth disease virus results in a rapid reduction in MHC class I surface expression. J. Gen. Virol. 79:433–436.
147. Serrano, P.,, M. Rodríguez Pulido,, M. Saiz, and, E. Martínez-Salas. 2006. The 3′ end of the foot-and-mouth disease virus genome establishes two distinct long-range RNA-RNA interactions with the 5′ end region. J. Gen. Virol. 87:3013–3022.
148. Strebel, K., and, E. Beck. 1986. A second protease of foot-and-mouth disease virus. J. Virol. 58:893–899.
149. Summerfield, A.,, L. Guzylack-Piriou,, L. Harwood, and, K. C. McCullough. 2009. Innate immune responses against foot-and-mouth disease virus: current understanding and future directions. Vet. Immunol. Immunopathol. 128:205–210.
150. Sutmoller, P., and, O. R. Casas. 2002. Unapparent foot and mouth disease infection (sub-clinical infections and carriers): implications for control. Rev. Sci. Tech. 21:519–529.
151. Sutmoller, P., and, A. Gaggero. 1965. Foot-and mouth diseases carriers. Vet. Rec. 77:968–969.
152. Sutmoller, P., and, J. W. McVicar. 1976. Pathogenesis of foot-and-mouth disease: the lung as an additional portal of entry of the virus. J. Hyg. (London) 77:235–243.
153. Sutmoller, P.,, J. W. McVicar, and, G. E. Cottral. 1968. The epizootiological importance of foot-and-mouth disease carriers. I. Experimentally produced foot-and-mouth disease carriers in susceptible and immune cattle. Arch. Gesamte Virus- forsch. 23:227–235.
154. Taboga, O.,, C. Tami,, E. Carrillo,, J. I. Nunez,, A. Rodriguez,, J. C. Saiz,, E. Blanco,, M. L. Valero,, X. Roig,, J. A. Camarero,, D. Andrue,, M. G. Mateu,, E. Giralt,, E. Domingo,, F. Sobrino, and, E. L. Palma. 1997. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71:2606–2614.
155. Tami, C.,, O. Taboga,, A. Berinstein,, J. I. Nunez,, E. L. Palma,, E. Domingo,, F. Sobrino, and, E. Carrillo. 2003. Evidence of coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo. J. Virol. 77:1219–1226.
156. Tesar, M., and, O. Marquardt. 1990. Foot-and-mouth disease virus protease 3C inhibits cellular transcription and mediates cleavage of histone H3. Virology 174:364–374.
157. Toka, F. N.,, C. K. Nfon,, H. Dawson,, D. M. Estes, and, W. T. Golde. 2009. Activation of porcine natural killer (NK) cells and lysis of foot-and-mouth disease virus (FMDV) infected cells. J. Interferon Cytokine Res. 29:47–60.
158. Vakharia, V. N.,, M. A. Devaney,, D. M. Moore,, J. J. Dunn, and, M. J. Grubman. 1987. Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell free system from clone-derived transcripts. J. Virol. 61:3199–3207.
159. van Bekkum J. G.,, H. S. Frenkel,, H. H. J. Frederiks, and, S. Frenkel. 1959. Observations on the carrier state of cattle exposed to foot-and-mouth disease virus. Tijdschr. Diergeneeskd. 84:1159–1164.
160. van Pesch, V.,, O. van Eyll, and, T. Michiels. 2001. The leader protein of Theiler’s virus inhibits immediate-early alpha/beta interferon production. J. Virol. 75:7811–7817.
161. Vosloo, W.,, A. D. Bastos,, E. Kirkbride,, J. J. Esterhuysen,, D. J. van Rensburg,, R. G. Bengis,, D. W. Keet, and, G. R. Thomson. 1996. Persistent infection of African buffalo (Syncerus caffer) with SAT-type foot-and-mouth disease viruses: rate of fixation of mutations, antigenic change and interspecies transmission. J. Gen. Virol. 77:1457–1467.
162. Wimmer, E. 1982. Genome-linked proteins of viruses. Cell 28:199–201.
163. Woodbury, E. L. 1995. A review of the possible mechanisms for the persistence of foot-and-mouth disease virus. Epidemiol. Infect. 114:1–13.
164. Yang, P. C.,, R. M. Chu,, W. B. Chung, and, H. T. Sung. 1999. Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. Vet. Rec. 145:731–734.
165. Zhang, Z.,, J. B. Bashiruddin,, C. Doel,, J. Horsington,, S. Du-rand, and, S. Alexandersen. 2006. Cytokine and Toll-like receptor mRNAs in the nasal-associated lymphoid tissues of cattle during foot-and-mouth disease virus infection. J. Comp. Pathol. 134:56–62.
166. Zhang, Z. D., and, R. P. Kitching. 2001. The localization of persistent foot and mouth disease virus in the epithelial cells of the soft palate and pharynx. J. Comp. Pathol. 124:89–94.

Tables

Foot-and-Mouth Disease
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816698.ch25-1,webId=/content/author/10.1128/9781555816698.ch25-1,properties={foaf_givenname=Marvin J., foaf_name=Marvin J. Grubman, foaf_surname=Grubman, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816698.ch25-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816698.ch25-2,webId=/content/author/10.1128/9781555816698.ch25-2,properties={foaf_givenname=Luis L., foaf_name=Luis L. Rodriguez, foaf_surname=Rodriguez, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816698.ch25-aff2]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816698.ch25-3,webId=/content/author/10.1128/9781555816698.ch25-3,properties={foaf_givenname=Teresa de los, foaf_name=Teresa de los Santos, foaf_surname=Santos, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816698.ch25-aff3]]}]]
Citation: Grubman M, Rodriguez L, Santos T. 2010. Foot-and-Mouth Disease, p 397-410. In Ehrenfeld E, Domingo E, Roos R (ed), The Picornaviruses. ASM Press, Washington, DC. doi: 10.1128/9781555816698.ch25
/content/10.1128/9781555816698.ch25.ch25tab01
Table 1.
Integrin receptors for FMDV
Generic image for table
Table 1.

Integrin receptors for FMDV

Citation: Grubman M, Rodriguez L, Santos T. 2010. Foot-and-Mouth Disease, p 397-410. In Ehrenfeld E, Domingo E, Roos R (ed), The Picornaviruses. ASM Press, Washington, DC. doi: 10.1128/9781555816698.ch25
/content/10.1128/9781555816698.ch25.ch25tab02
Table 2.
Summary of FMDV proteins that affect the host immune response
Generic image for table
Table 2.

Summary of FMDV proteins that affect the host immune response

Citation: Grubman M, Rodriguez L, Santos T. 2010. Foot-and-Mouth Disease, p 397-410. In Ehrenfeld E, Domingo E, Roos R (ed), The Picornaviruses. ASM Press, Washington, DC. doi: 10.1128/9781555816698.ch25

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error